KCM
RETA

KRS Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

KRS Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$2.85M Sell
2023
Q1 		$2.56M Hold
2022
Q4 		$1.07M Hold
2022
Q3 		$707K Hold
2022
Q2 		$855K Hold
2022
Q1 		$921K Sell
2021
Q4 		$866K Buy